Integrated Proteogenomic Characterization across Major Histological Types of Pediatric Brain Cancer is a research paper published in Cell (2020). On theSindex it has a DataRank of 0.878. It has been cited 347 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.878
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NINDS NIH HHS
Grant: R01 NS091620
NCI NIH HHS
Grant: U24 CA210993
NICHD NIH HHS
Grant: U2C HD109731
NCI NIH HHS
Grant: P30 CA008748
NINDS NIH HHS
Grant: R01 NS085336
NCI NIH HHS
Grant: U01 CA214114
NHLBI NIH HHS
Grant: U2C HL138346
NCI NIH HHS
Grant: R50 CA211499
NCI NIH HHS
Grant: U24 CA210967
NCI NIH HHS
Grant: U24 CA210972
NCI NIH HHS
Grant: U24 CA210954
NCI NIH HHS
Grant: U24 CA210979
NCI NIH HHS
Grant: U24 CA210985
NIGMS NIH HHS
Grant: R01 GM067945
NCI NIH HHS
Grant: U24 CA210955
National Institutes of Health
Grant: 5U24CA210954-04
iPGDAC, An Integrative Proteogenomic Data Analysis Center for CPTAC
National Institutes of Health
Grant: 5U24CA210985-03
The Comprehensive Proteome Characterization Center at Johns Hopkins: High Precision Discovery and Confirmation of Genoproteomic Targets
National Institutes of Health
Grant: 5U24CA210993-04
Systems Biology based Proteogenomic Translator for Cancer Marker Discovery towards Precision Medicine
National Institutes of Health
Grant: 1U24CA210972-01
Proteogenomic Data Analysis for Cancer Systems Biology and Clinical Translation
National Institutes of Health
Grant: 1U24CA210979-01
Integrated high throughput proteogenomic data analysis center for CPTAC
Fundação para a Ciência e a Tecnologia, I.P.
Grant: PTDC/CCI-INF/6762/2020
MS3: New foundations for micro-services and serverless systems
National Institutes of Health
Grant: 5U24CA210967-04
University of Michigan Proteogenomics Data Analysis Center
U.S. Department of Energy
National Institutes of Health
FWCI
13.94
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Transcriptional immunogenomic analysis reveals distinct immunological clusters in paediatric nervous system tumours
Additional file 1 of Transcriptional immunogenomic analysis reveals distinct immunological clusters in paediatric nervous system tumours
Additional file 2 of Robust classification using average correlations as features (ACF)
Additional file 2 of Robust classification using average correlations as features (ACF)
Additional file 1 of Ganglioglioma deep transcriptomics reveals primitive neuroectoderm neural precursor-like population
Additional file 1 of Ganglioglioma deep transcriptomics reveals primitive neuroectoderm neural precursor-like population
Additional file 13 of Ganglioglioma deep transcriptomics reveals primitive neuroectoderm neural precursor-like population
Additional file 13 of Ganglioglioma deep transcriptomics reveals primitive neuroectoderm neural precursor-like population
Additional file 1 of Recurrent adamantinomatous craniopharyngiomas show MAPK pathway activation, clonal evolution and rare TP53-loss-mediated malignant progression
Additional file 1 of Recurrent adamantinomatous craniopharyngiomas show MAPK pathway activation, clonal evolution and rare TP53-loss-mediated malignant progression
Additional file 2 of Recurrent adamantinomatous craniopharyngiomas show MAPK pathway activation, clonal evolution and rare TP53-loss-mediated malignant progression
Additional file 2 of Recurrent adamantinomatous craniopharyngiomas show MAPK pathway activation, clonal evolution and rare TP53-loss-mediated malignant progression
Additional file 3 of Recurrent adamantinomatous craniopharyngiomas show MAPK pathway activation, clonal evolution and rare TP53-loss-mediated malignant progression
Additional file 3 of Recurrent adamantinomatous craniopharyngiomas show MAPK pathway activation, clonal evolution and rare TP53-loss-mediated malignant progression
Additional file 4 of Recurrent adamantinomatous craniopharyngiomas show MAPK pathway activation, clonal evolution and rare TP53-loss-mediated malignant progression
Additional file 4 of Recurrent adamantinomatous craniopharyngiomas show MAPK pathway activation, clonal evolution and rare TP53-loss-mediated malignant progression
Additional file 5 of Recurrent adamantinomatous craniopharyngiomas show MAPK pathway activation, clonal evolution and rare TP53-loss-mediated malignant progression
Additional file 5 of Recurrent adamantinomatous craniopharyngiomas show MAPK pathway activation, clonal evolution and rare TP53-loss-mediated malignant progression
Additional file 6 of Recurrent adamantinomatous craniopharyngiomas show MAPK pathway activation, clonal evolution and rare TP53-loss-mediated malignant progression
Additional file 6 of Recurrent adamantinomatous craniopharyngiomas show MAPK pathway activation, clonal evolution and rare TP53-loss-mediated malignant progression